Sanofi (SNY) has voluntarily recalled nine lots of Thymoglobulin, its drug for treating kidney...


Sanofi (SNY) has voluntarily recalled nine lots of Thymoglobulin, its drug for treating kidney rejection in transplant patients, after one of the lots failed a periodic stability test. The FDA says Sanofi, which carried out the recall earlier this month, has not learned of any safety problems connected to the failure.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs